Innovation For
Mental Health
NeuraWell is a clinical-stage research and development company focused on developing safe and effective medicines for the potential treatment of various CNS disorders.
These target disorders include a primary focus on major depressive disorder (MDD), treatment-resistant depression (TRD), and treatment-resistant anxiety.
NeuraWell Therapeutics
433 Plaza Real, Suite 275
Boca Raton, FL 33432
This website is intended for U.S. residents only. This website contains information about pharmaceutical research. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.
© Copyright 2018 - 2024| NeuraWell Therapeutics | All Rights Reserved | Site Design & SEO by CICOR Marketing
